Skip to main content
SpringerLink
Log in

The manufacturers of domperidone, in collaboration with Health Canada, have issued a ‘Dear Healthcare Professional’ letter

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Mathivanan M.Domperidone Maleate - Association with Serious Abnormal Heart Rhythms and Sudden Death (Cardiac Arrest) - For Health Professionals. Internet Document: [3 pages], 2 Mar 2012. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The manufacturers of domperidone, in collaboration with Health Canada, have issued a ‘Dear Healthcare Professional’ letter. React. Wkly. 1394, 4 (2012). https://doi.org/10.2165/00128415-201213940-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213940-00010

Keywords

Search

Navigation